JPH10503468A - 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体 - Google Patents

低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体

Info

Publication number
JPH10503468A
JPH10503468A JP7524645A JP52464595A JPH10503468A JP H10503468 A JPH10503468 A JP H10503468A JP 7524645 A JP7524645 A JP 7524645A JP 52464595 A JP52464595 A JP 52464595A JP H10503468 A JPH10503468 A JP H10503468A
Authority
JP
Japan
Prior art keywords
oxo
hydrogen
alkyl
thio
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP7524645A
Other languages
English (en)
Japanese (ja)
Inventor
フリン，ゲアリー・エイ
フレンチ，ジヨン・エフ
ダーゲ，リチヤード・シー
Original Assignee
メリル・フアーマシユウテイカルズ・インコーポレイテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メリル・フアーマシユウテイカルズ・インコーポレイテツド filed Critical メリル・フアーマシユウテイカルズ・インコーポレイテツド
Publication of JPH10503468A publication Critical patent/JPH10503468A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP7524645A 1994-03-24 1995-02-28 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体 Ceased JPH10503468A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21747194A 1994-03-24 1994-03-24
US08/217,471 1994-03-24
PCT/US1995/002448 WO1995025519A1 (en) 1994-03-24 1995-02-28 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives

Publications (1)

Publication Number Publication Date
JPH10503468A true JPH10503468A (ja) 1998-03-31

Family

ID=22811224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7524645A Ceased JPH10503468A (ja) 1994-03-24 1995-02-28 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体

Country Status (18)

Country Link
US (1) US6013645A (de)
EP (1) EP0751774B1 (de)
JP (1) JPH10503468A (de)
CN (1) CN1144482A (de)
AT (1) ATE246927T1 (de)
AU (1) AU688012B2 (de)
CA (1) CA2184692C (de)
DE (1) DE69531489T2 (de)
DK (1) DK0751774T3 (de)
ES (1) ES2201100T3 (de)
FI (1) FI963784A0 (de)
HU (1) HUP9774624A2 (de)
IL (1) IL113073A (de)
NO (1) NO963988L (de)
NZ (1) NZ282565A (de)
PT (1) PT751774E (de)
WO (1) WO1995025519A1 (de)
ZA (1) ZA952289B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
GB0119305D0 (en) * 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) * 1965-03-25 1967-08-01 Sandoz Ag Sedatives
GB1525845A (en) * 1976-07-30 1978-09-20 Ucb Sa 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (de) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
NZ204130A (en) * 1982-05-12 1986-03-14 Hoffmann La Roche Bicyclic heterocyclic compounds and pharmaceutical compositions
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
ATE60605T1 (de) * 1985-04-30 1991-02-15 Lilly Co Eli 7-substituierte bicyclische pyrazolidinone.
ZA874107B (de) * 1986-06-13 1987-12-09
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
ZA874106B (en) * 1986-06-13 1987-12-08 Merrell Dow Pharmaceuticals Inc. Novel antihypertensive agent
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
WO1991009840A1 (en) * 1989-12-22 1991-07-11 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
ATE195653T1 (de) * 1990-06-06 2000-09-15 Ruth Korth Behandlung von erkrankungen mit paf-antagonisten und verfahren zur bestimmung deren wirksamkeit
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
EP0492369B1 (de) * 1990-12-21 1997-09-17 Merrell Pharmaceuticals Inc. Neue trizyklische Amino- und Nitro Verbindungen mit ACE-hemmenden Eigenschaften
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
EP0567026B1 (de) * 1992-04-20 2003-03-26 Takeda Chemical Industries, Ltd. 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase

Also Published As

Publication number Publication date
AU688012B2 (en) 1998-03-05
FI963784A7 (fi) 1996-09-23
ES2201100T3 (es) 2004-03-16
CA2184692C (en) 2001-01-02
US6013645A (en) 2000-01-11
DE69531489D1 (de) 2003-09-18
HUP9774624A2 (en) 1997-01-28
NZ282565A (en) 1999-11-29
ATE246927T1 (de) 2003-08-15
EP0751774A1 (de) 1997-01-08
AU1972095A (en) 1995-10-09
IL113073A (en) 2001-03-19
CA2184692A1 (en) 1995-09-28
WO1995025519A1 (en) 1995-09-28
PT751774E (pt) 2003-11-28
HU9602602D0 (en) 1996-11-28
IL113073A0 (en) 1995-06-29
FI963784L (fi) 1996-09-23
DE69531489T2 (de) 2004-04-08
ZA952289B (en) 1996-01-09
DK0751774T3 (da) 2003-12-08
EP0751774B1 (de) 2003-08-13
FI963784A0 (fi) 1996-09-23
CN1144482A (zh) 1997-03-05
NO963988D0 (no) 1996-09-23
NO963988L (no) 1996-11-22

Similar Documents

Publication Publication Date Title
EP0372542B1 (de) Hypocholesterolämische und antiatherosklerotische Verwendung von bis-(3,5-di-tertiärbutyl-4-hydroxyphenylthio)methan
US20260014072A1 (en) Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
KR20170015312A (ko) 카스파제 억제제를 사용한 만성 간질환의 합병증의 치료
EP2263694A1 (de) Antitumormittel, enthaltend den Histon-deacetylase-inhibitor FK228 und einen Topoisomerase-II-Inhibitor
KR101516677B1 (ko) 지방성 간 질환의 치료용 의약 조성물
US9717718B2 (en) Anti-inflammatory compounds
JPH03151328A (ja) 冠動脈のアテローム硬化の退行または安定化用薬剤
JP6509244B2 (ja) 水晶体硬化抑制剤
JPH10503468A (ja) 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体
AU705029B2 (en) Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
EP3928835B1 (de) Wasserlösliches makromolekulares derivat von venetoclax
WO2019009359A1 (ja) 経鼻投与用医薬組成物
EP0745080B1 (de) Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren
WO2005055997A1 (ja) 炎症性疾患の治療及び予防用医薬組成物
EP0751783B1 (de) Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
KR100356899B1 (ko) 궤양성 대장염 및/또는 크론병 예방 및 치료제
JPWO2002074299A1 (ja) ＴＮＦα産生抑制剤
JPWO1999003504A1 (ja) 免疫不全症治療用医薬組成物

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041026

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20050318

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050809